Non-invasive prenatal testing (NIPT) is an advanced screening method that analyses cell-free fetal DNA circulating in maternal blood, providing high accuracy in the detection of specific chromosomal abnormalities. It can be performed from the early weeks of pregnancy and poses no procedural risk to either the mother or the fetus, making it a particularly safe and well-tolerated screening option.
NIPT is primarily used to assess the risk of chromosomal conditions such as Down syndrome (trisomy 21), as well as other common aneuploidies. It is not a diagnostic test but a highly sensitive screening tool that supports evidence-based decision-making regarding the need for further diagnostic evaluation during pregnancy.
When Is It Recommended
It is recommended in cases of increased risk, such as advanced maternal age, abnormal ultrasound findings, or positive results from prior prenatal screening tests, but it may also be performed electively as part of routine prenatal care.
Advantages and Limitations
The primary advantage of NIPT lies in its high sensitivity and safety profile. However, in the event of a positive result, confirmation with an invasive diagnostic test is required.
The Role of Counselling
Appropriate medical counselling both before and after testing is essential. Clear explanation of the capabilities and limitations of NIPT enables the pregnant woman and her partner to understand the results accurately and to proceed with confidence and reassurance in the ongoing management of the pregnancy.